Skip to main content
. Author manuscript; available in PMC: 2026 Nov 12.
Published in final edited form as: Cancer Cell. 2025 Dec 31;44(1):221–234.e5. doi: 10.1016/j.ccell.2025.12.004

Figure 2. T-bet+ intermediate exhausted melanoma-specific CD8+ T cells in post-treatment tumors are associated with pathologic response.

Figure 2.

(A) Seventy-nine post-treatment tumor immune parameters classified by pathologic response using random forest analysis and ranked by importance score. Error bar denotes mean +/− s.d. for 1,000 random forest iterations.

(B) Representative flow plot of the percentage of melanoma-specific CD8+ T cells in pCR and in pNR patient.

(C) Percentage of dominant melanoma-specific CD8+ T cells stratified by response in the tumor. Each dot represents dominant tetramer+ population in individual patient. The bar and error bars indicate the mean ± SEM.

(D) Percentage of melanoma-specific CD8+ T cells in the tumor before and after treatment in responders and non-responders. Each line connects paired timepoints from the same patient.

(E) Pathologic response rate stratified by CART-defined percentage of dominant melanoma-specific CD8+ T cell threshold (0.08%) in the tumor.

(F) Representative flow plots comparing T-bet and CD39 expressions on melanoma-specific CD8+ T cells in pCR and pNR patient.

(G) Percentage of T-bet+ melanoma-specific CD8+ T cells stratified by response in the tumor. Each dot represents an individual tetramer+ population. The box and whiskers indicate the median and interquartile range (IQR; Q1–Q3) with whiskers extending to 1.5× IQR.

(H) CD39 MFI melanoma-specific CD8+ T cells stratified by response in the tumor. Each dot represents an individual tetramer+ population. The box and whiskers indicate the median and interquartile range (IQR; Q1–Q3) with whiskers extending to 1.5× IQR.

(I) Pathologic response rate stratified by CART-defined T-bet threshold (11.8%) in the tumor.

(J) Representative flow plot of TCF-1, TIM-3, TOX, and CD39 expressions on T-bet+ melanoma-specific CD8+ T cells in the tumor.

(K) Cell state composition of T-bet+ melanoma-specific CD8+ T cells in the tumor.

(L) Percentage of intermediate exhausted CD8+ T cells stratified by response in the tumor. Each dot represents an individual tetramer+ population. The box and whiskers indicate the median and interquartile range (IQR; Q1–Q3) with whiskers extending to 1.5× IQR.

Statistical significance was assessed using the Wilcoxon rank-sum test for unpaired comparisons and the Wilcoxon signed-rank test for paired comparisons. P-values are reported as follows: ns (not significant), *p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001, ****p ≤ 0.0001.

See also Figure S4.